Ceraxa (nanoliposomal ceramide)

News alerts, weekly reports and conference planners

Company:

Keystone Nano

Drug class:

Apoptosis inducer, PP2A activator

Related drugs:

BRAF T1799A	Breast Cancer	BRAF T1799A	Breast Cancer	sorafenib + nanoliposomal ceramide Sensitive: D – Preclinical sorafenib + nanoliposomal ceramide Sensitive : D	sorafenib + nanoliposomal ceramide Sensitive: D – Preclinical sorafenib + nanoliposomal ceramide Sensitive : D
BRAF T1799A	Melanoma	BRAF T1799A	Melanoma	sorafenib + nanoliposomal ceramide Sensitive: D – Preclinical sorafenib + nanoliposomal ceramide Sensitive : D	sorafenib + nanoliposomal ceramide Sensitive: D – Preclinical sorafenib + nanoliposomal ceramide Sensitive : D

Associations
(2)